Pirkko Sulila Tamsen
Chief Executive Officer at Arandi Innovation AB
Profile
Pirkko Sulila Tamsen currently works at Arandi Development AB, as Deputy Chief Executive Officer, Arandi Innovation AB, as Chairman & Chief Executive Officer from 2008, Oerebro Universitet Uppdrag AB, as Director, Oerebro Universitet Enterprise AB, as Director, Hepapredict AB, as Director, and C26 Bioscience AB, as Director.
Dr. Tamsen also formerly worked at SEDOC Pharmaceutical Medicine AB, as Chief Executive Officer, NovaSAID AB, as Chief Executive Officer from 2008 to 2013, Modus Therapeutics AB, as Chief Executive Officer from 2011 to 2013, Arandi Holdings AB, as Deputy Chief Executive Officer, Curenc AB, as Chairman, Karolinska Institutet Innovations AB, as Director from 2014 to 2017, Orebro Universitet Holding AB, as Director, AlzeCure Pharma AB, as Director, Rapp AB, as Director in 2018, Uppsala Universitet Innovation Tools AB, as Director, Uppsala Berzelii Technology Centre For Neurodiagnostics, as Director, Astra AB, as Principal, A+ Science AB, as Principal, Kabi Pharmacia, as Principal, Uppsala University Innovation, as Manager, and OncoZenge AB, as Chief Operating Officer from 2021 to 2023.
Dr. Tamsen received her graduate degree and doctorate degree from the University of Uppsala.
Pirkko Sulila Tamsen active positions
| Companies | Position | Start |
|---|---|---|
| Arandi Innovation AB | Chief Executive Officer | 31/07/2008 |
| Oerebro Universitet Uppdrag AB | Director/Board Member | - |
Oerebro Universitet Enterprise AB
 Oerebro Universitet Enterprise AB Miscellaneous Commercial ServicesCommercial Services Oerebro Universitet Enterprise AB is a Swedish company that engages in other scientific and technical research & development. The private company is based in Örebro, Sweden. | Director/Board Member | - |
| Hepapredict AB | Director/Board Member | - |
| C26 Bioscience AB | Director/Board Member | - |
Arandi Development AB
 Arandi Development AB Pharmaceuticals: MajorHealth Technology Arandi Development AB is a Swedish pharmaceutical manufacturing company. The private company is based in Stockholm, Sweden. | Corporate Officer/Principal | - |
Former positions of Pirkko Sulila Tamsen
| Companies | Position | End |
|---|---|---|
| ONCOZENGE AB | Chief Executive Officer | 31/10/2021 |
Rapp AB
 Rapp AB Information Technology ServicesTechnology Services Rapp AB is a healthcare company based in Örebro, Sweden that provides a systematic approach to postoperative care and quality control. Rapp's innovation, developed by Professor Ulrica Nilsson, involves the use of a patient questionnaire to track their recovery progress and provide quality data to healthcare providers. The goal is to increase patient participation, knowledge, and security while reducing the need for unplanned contacts with healthcare providers. Rapp has won the World Innovation Summit for Health award in 2021. The Swedish company was founded in 2015 by Björn Pettersson and Ulrica Nilsson, with Anders Harald Thunberg as the current CEO. | Director/Board Member | 30/09/2018 |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Director/Board Member | 28/02/2017 |
| ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Pirkko Sulila Tamsen
| University of Uppsala | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALZECURE PHARMA AB | Health Technology |
| ONCOZENGE AB | Health Technology |
| Private companies | 20 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
A+ Science AB
 A+ Science AB Miscellaneous Commercial ServicesCommercial Services A+ Science AB plans and conducts clinical trials for pharmaceutical and medical device companies. It offers outsourced research services to pharmaceutical companies. The company was founded in 1997 and is headquartered in Stockholm, Sweden. | Commercial Services |
Arandi Development AB
Arandi Development AB Pharmaceuticals: MajorHealth Technology Arandi Development AB is a Swedish pharmaceutical manufacturing company. The private company is based in Stockholm, Sweden. | Health Technology |
| SEDOC Pharmaceutical Medicine AB | Health Technology |
| Kabi Pharmacia | |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Finance |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Health Technology |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
Orebro Universitet Holding AB
 Orebro Universitet Holding AB Miscellaneous Commercial ServicesCommercial Services Orebro Universitet Holding AB provides scientific, technical research and development services. The private company is based in Örebro, Sweden. | Commercial Services |
Rapp AB
Rapp AB Information Technology ServicesTechnology Services Rapp AB is a healthcare company based in Örebro, Sweden that provides a systematic approach to postoperative care and quality control. Rapp's innovation, developed by Professor Ulrica Nilsson, involves the use of a patient questionnaire to track their recovery progress and provide quality data to healthcare providers. The goal is to increase patient participation, knowledge, and security while reducing the need for unplanned contacts with healthcare providers. Rapp has won the World Innovation Summit for Health award in 2021. The Swedish company was founded in 2015 by Björn Pettersson and Ulrica Nilsson, with Anders Harald Thunberg as the current CEO. | Technology Services |
| Arandi Innovation AB | |
Curenc AB
 Curenc AB BiotechnologyHealth Technology Curenc AB engages in the research and development of pharmaceutical products. It develops a peptide that kills various types of bacteria including multi-resistant staphylococcus. The company is headquartered in Sweden. | Health Technology |
| Oerebro Universitet Uppdrag AB | |
Oerebro Universitet Enterprise AB
Oerebro Universitet Enterprise AB Miscellaneous Commercial ServicesCommercial Services Oerebro Universitet Enterprise AB is a Swedish company that engages in other scientific and technical research & development. The private company is based in Örebro, Sweden. | Commercial Services |
| Hepapredict AB | |
| C26 Bioscience AB | |
| Uppsala Universitet Innovation Tools AB | |
| Arandi Holdings AB | |
| Uppsala Berzelii Technology Centre For Neurodiagnostics | |
| Uppsala University Innovation |
- Stock Market
- Insiders
- Pirkko Sulila Tamsen
